Yamanouchi Pharmaceutical

Following pharmaceuticals, consumer products constitute the second pillar of the Company' s operations, which include nutritional supplements and other items marketed by Shaklee Corporation, of the United States, and Shaklee Japan K.K.. European operations: Yamanouchi Europe B.V. (YEU), conducts sales through bases in 13 countries and exports to more than 30 other countries and regions. Key areas of activity include the development and marketing of urological, dermatological, gastroenterological, anti-infective and cardiovascular products.With its clinical pharmacology units and specialized staff, YEU also oversees clinical development in Europe. Regarding manufacturing, YEU operates factories in Italy the Netherlands. Yamanouchi Ireland Co., Ltd., which serves as a bulk production base for the European and North American markets, boasts state-of-the-art plants that have cleared the British BS7750 as well as the international ISO 14000 series environmental standards and ISO9000 series quality control for manufacturing famotidine, nicardipine, and other products.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: Asia , Europe , North America

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: